EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells

Emilien Billon, Caroline Imbert, Damien Bruyat, Pierre Grassi, Lucie Robert, Téo Fernez, Philippe Livrati, Amira Ben Amara, Marie-Sarah Rouvière, Manon Richaud, Nicolas Boucherit, Jacques A Nunès und 6 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Emilien Billon und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Cancérologie de Marseille, CRCM, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, Aix Marseille Univ, Marseil…. Hauptthemen laut MEDLINE: Butyrophilins, Receptors, Antigen, T-Cell, gamma-delta, Trogocytosis, Cytotoxicity, Immunologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ARC Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyrophilinsReceptors, Antigen, T-Cell, gamma-deltaTrogocytosisCytotoxicity, ImmunologicT-LymphocytesNeoplasmsHumansCell Line, TumorFemaleMonocytesLymphocyte Activation

Stichwörter der Autor:innen

BTN2A1CP: CancerCP: ImmunologyVγ9Vδ2 T cellsbutyrophilinsendometrial cancertrogocytosisγδ T cells

Substanzen

ButyrophilinsReceptors, Antigen, T-Cell, gamma-delta

Autor:innen und Institutionen

  • Centre de Recherche en Cancérologie de Marseille, CRCM, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, Aix Marseille Univ, Marseille, France; Immunomonitoring Department, Institut Paoli-Calmettes, Mar…
  • Centre de Recherche en Cancérologie de Marseille, CRCM, Cytometry Platform, Institut Paoli-Calmettes, INSERM, CNRS, Aix Marseille Univ, Marseille, France.
  • Centre de Recherche en Cancérologie de Marseille, CRCM, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, Aix Marseille Univ, Marseille, France. Electronic address: jacques.nunes@inserm.fr.
  • Medical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France.

Förderung

  • ARC Foundation for Cancer Research

Zitieren

APA

Billon, E., Imbert, C., Bruyat, D., Grassi, P., Robert, L., Fernez, T., Livrati, P., Ben Amara, A., Rouvière, M. S., Richaud, M., Boucherit, N., Nunès, J. A., Sabatier, R., Lambaudie, É., Chrétien, A. S., Gravis, G., Gorvel, L., & Olive, D. (2025). BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116387

Vancouver

Billon E, Imbert C, Bruyat D, Grassi P, Robert L, Fernez T, et al. BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116387

BibTeX
@article{Billon2025,
  author = {Billon, Emilien and Imbert, Caroline and Bruyat, Damien and Grassi, Pierre and Robert, Lucie and Fernez, Téo and Livrati, Philippe and Ben Amara, Amira and Rouvière, Marie-Sarah and Richaud, Manon and Boucherit, Nicolas and Nunès, Jacques A and Sabatier, Renaud and Lambaudie, Éric and Chrétien, Anne-Sophie and Gravis, Gwenaëlle and Gorvel, Laurent and Olive, Daniel},
  title = {BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116387}
}
Kostenlos starten →